Genotype-phenotype correlation on 45 individuals with West syndrome.


Journal

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
ISSN: 1532-2130
Titre abrégé: Eur J Paediatr Neurol
Pays: England
ID NLM: 9715169

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 12 07 2019
revised: 22 09 2019
accepted: 21 11 2019
pubmed: 4 12 2019
medline: 1 9 2020
entrez: 4 12 2019
Statut: ppublish

Résumé

West syndrome is an epilepsy syndrome characterized by repetitive epileptic spasms (ES) and hypsarrhythmia, typically leading to developmental delay/intellectual disability (DD/ID). It is considered a classic epileptic encephalopathy (EE). We designed a diagnostic sequencing panel targeting 131 genes associated with epilepsy and/or EE and screened a cohort of 45 individuals with clinical diagnosis of West syndrome. We identified disease-causing single nucleotide variants in 11 out of 45 individuals affecting genes commonly associated with West syndrome (such as CDKL5, ARX) but also in genes predominantly linked to other epileptic disorders (such as DEPDC5, SCN1A, WDR45, AARS). Panel analysis revealed copy number variants in two additional cases, comprising a 6,7 Mb Duplication on chromosome 2 including SCN2A and SCN3A and a supernumerary marker chromosome 15 leading to an overall diagnostic yield of 29% (13/45). In our cohort, individuals with a disease-causing variant had significantly more severe phenotypes with respect to DD/ID, therapy resistant epilepsy and cerebral atrophy compared to genetically unclarified cases. In addition to investigating the genotypic spectrum of West syndrome, we compared the phenotypic spectrum of clarified versus unclarified cases. Our study illustrates that West syndrome is an electroclinical syndrome caused by various genetic disorders. Individuals without detectable genetic cause might have less encephalopathy leading to a less severe course.

Identifiants

pubmed: 31791873
pii: S1090-3798(19)30419-2
doi: 10.1016/j.ejpn.2019.11.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

134-138

Informations de copyright

Copyright © 2019 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Auteurs

Ilona Krey (I)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany. Electronic address: ilona.krey@medizin.uni-leipzig.de.

Janna Krois-Neudenberger (J)

Department of General Pediatrics, Division of Neuropediatrics, University Hospital Muenster, Germany. Electronic address: Janna.Krois-Neudenberger@ukmuenster.de.

Julia Hentschel (J)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany. Electronic address: Julia.Hentschel@medizin.uni-leipzig.de.

Steffen Syrbe (S)

Division of Child Neurology and Metabolic Medicine, Center for Paediatrics and Adolescent Medicine, University Hospital Heidelberg, Germany. Electronic address: Steffen.Syrbe@med.uni-heidelberg.de.

Tilman Polster (T)

Bethel Epilepsy Center, Mara Hospital, Bielefeld, Germany. Electronic address: Tilman.Polster@mara.de.

Britta Hanker (B)

Institute of Human Genetics, University of Lübeck, Lübeck, Germany. Electronic address: Britta.Hanker@uksh.de.

Barbara Fiedler (B)

Department of General Pediatrics, Division of Neuropediatrics, University Hospital Muenster, Germany. Electronic address: Barbara.Fiedler@ukmuenster.de.

Gerhardt Kurlemann (G)

Hospital for Children, Bonifatius Hospital Lingen, Germany. Electronic address: gerdkurlemann@gmail.com.

Johannes R Lemke (JR)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany. Electronic address: Johannes.Lemke@medizin.uni-leipzig.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH